Cargando…
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
PURPOSE: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma. METHODS: A total of 15 eyes of 15 patients with intractable neovascular glaucoma with intraocular pressure (IOP) ≥28 mmHg not responding to medical treatment were retrospectively ana...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367580/ https://www.ncbi.nlm.nih.gov/pubmed/28356708 http://dx.doi.org/10.2147/OPTH.S128956 |
_version_ | 1782517798539362304 |
---|---|
author | Alsmman, Alahmady H Radwan, Gamal Elagouz, Mohammed Mohammed, Usama Ali |
author_facet | Alsmman, Alahmady H Radwan, Gamal Elagouz, Mohammed Mohammed, Usama Ali |
author_sort | Alsmman, Alahmady H |
collection | PubMed |
description | PURPOSE: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma. METHODS: A total of 15 eyes of 15 patients with intractable neovascular glaucoma with intraocular pressure (IOP) ≥28 mmHg not responding to medical treatment were retrospectively analyzed. All patients had poor visual acuity and underwent Alahmady ring implantation. The ring was designed from fenestrated silicon tube used in lacrimal surgeries and was implanted subsclerally after passing it through the anterior chamber. Patients were followed up for at least 24 months. Success in this study was defined based on IOP ≥8 mmHg and <21 mmHg, with not more than 1 glaucoma drug, and improvement of patient symptoms and signs with maximum use of beta blocker as antiglaucoma drug. RESULTS: A total of 15 eyes of 15 patients (9 males [60%] and 6 females [40%]) were analyzed in this study. The mean IOP before surgery was 38.6 mmHg (standard deviation [SD]: 6.98) and it was 14.05 mmHg (SD =7.57) after surgery. The follow-up range was 24–36 months. Success of silicon drainage device was defined as an IOP <21 mmHg on the last follow-up visit. Medications included only beta-blockers and topical steroids for those who were without severe complications or for those who were not in a condition to undergo a further glaucoma surgery. CONCLUSION: Alahmady ring implantation proves to be a good surgical option for neovascular glaucoma; however, a longer follow-up period is recommended. |
format | Online Article Text |
id | pubmed-5367580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53675802017-03-29 The efficacy of Alahmady ring implantation in the management of neovascular glaucoma Alsmman, Alahmady H Radwan, Gamal Elagouz, Mohammed Mohammed, Usama Ali Clin Ophthalmol Original Research PURPOSE: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma. METHODS: A total of 15 eyes of 15 patients with intractable neovascular glaucoma with intraocular pressure (IOP) ≥28 mmHg not responding to medical treatment were retrospectively analyzed. All patients had poor visual acuity and underwent Alahmady ring implantation. The ring was designed from fenestrated silicon tube used in lacrimal surgeries and was implanted subsclerally after passing it through the anterior chamber. Patients were followed up for at least 24 months. Success in this study was defined based on IOP ≥8 mmHg and <21 mmHg, with not more than 1 glaucoma drug, and improvement of patient symptoms and signs with maximum use of beta blocker as antiglaucoma drug. RESULTS: A total of 15 eyes of 15 patients (9 males [60%] and 6 females [40%]) were analyzed in this study. The mean IOP before surgery was 38.6 mmHg (standard deviation [SD]: 6.98) and it was 14.05 mmHg (SD =7.57) after surgery. The follow-up range was 24–36 months. Success of silicon drainage device was defined as an IOP <21 mmHg on the last follow-up visit. Medications included only beta-blockers and topical steroids for those who were without severe complications or for those who were not in a condition to undergo a further glaucoma surgery. CONCLUSION: Alahmady ring implantation proves to be a good surgical option for neovascular glaucoma; however, a longer follow-up period is recommended. Dove Medical Press 2017-03-20 /pmc/articles/PMC5367580/ /pubmed/28356708 http://dx.doi.org/10.2147/OPTH.S128956 Text en © 2017 Alsmman et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Alsmman, Alahmady H Radwan, Gamal Elagouz, Mohammed Mohammed, Usama Ali The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title | The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_full | The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_fullStr | The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_full_unstemmed | The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_short | The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_sort | efficacy of alahmady ring implantation in the management of neovascular glaucoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367580/ https://www.ncbi.nlm.nih.gov/pubmed/28356708 http://dx.doi.org/10.2147/OPTH.S128956 |
work_keys_str_mv | AT alsmmanalahmadyh theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT radwangamal theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT elagouzmohammed theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT mohammedusamaali theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT alsmmanalahmadyh efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT radwangamal efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT elagouzmohammed efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT mohammedusamaali efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma |